NCT05047874

High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19

Comparison of High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19 - Retrospective Cross-sectional Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Biruni University · Academic / Other
• Sex: All
• Age: 18 Years – 105 Years
• Healthy volunteers: Not accepted

Summary

In this study, we aimed to compare, retrospectively, the 15-day continuous hemodynamic, laboratory and clinical course of COVID 19 patients to whom we administered short-term (3 days) high-dose (1000 mg) systemic methylprednisolone with those to whom low-dose long-term (2x 40 mg) systemic methylprednisolone was administered.

Conditions

• Short-term (3 Days) High-dose (1000 mg) Systemic Methylprednisolone

Interventions

Type	Name	Description
BEHAVIORAL	systemic methylprednisolone	short-term (3 days) high-dose (1000 mg) systemic methylprednisolone and low-dose long-term (2x 40 mg) systemic methylprednisolone

Timeline

• Start date: 2021-09-20
• Primary completion: 2021-10-20
• Completion: 2021-10-30
• First posted: 2021-09-17
• Last updated: 2021-09-17

Locations

1 site across 1 country: Turkey (Türkiye)